1.
Eur Urol Focus
; 7(3): 503-505, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33896710
RESUMO
ReIMAGINE Screening is a single-centre study assessing the feasibility of biparametric magnetic resonance imaging as a screening tool for prostate cancer. The study outcomes will take us a step towards more accurate and less harmful prostate cancer screening.